A peer support community, independent and not for sale. Since February 2024.

GLP CircleA peer support community

symptoms

Pancreatitis: the symptoms to know

Uncommon, serious, and the reason this community has a low threshold for getting abdominal pain seen. The presentation, the evidence, and what to do.

8 min read1.1k wordsUpdated 19 June 2026Reviewed by Mira

Read this one now, not later

This is a short guide about an uncommon problem, and the reason it exists is that the cost of not knowing is high and the cost of knowing is four minutes.

Acute pancreatitis is inflammation of the pancreas. Most cases in the general population are caused by gallstones or by alcohol. It is usually treated in hospital, most people recover, and a minority become seriously unwell. It is not something to manage at home under any circumstances, and it is not something anybody can distinguish from severe indigestion by feel — including the person having it, and including us.

Mira, who spent eleven years on a metabolic ward before she came to peer support, wrote this section and asked us to keep it blunt: if the pain in this guide is your pain, the correct action is to be assessed today. Nothing else in this guide matters as much as that sentence.

What it feels like

The classic presentation is specific enough to be worth memorising.

  • Severe pain in the upper abdomen, usually central or slightly left, coming on over minutes to an hour or two.
  • Boring through to the back. This is the detail that most distinguishes it. People describe it as a band, or as being run through.
  • Worse lying flat, better leaning forward or curling up. Members who have had it describe sitting hunched on the edge of a bed at three in the morning.
  • Persistent rather than coming in waves. It does not settle after twenty minutes the way colic does.
  • Vomiting, often repeatedly, and often without relief.
  • Sometimes fever, a fast heart rate, feeling profoundly unwell, or a swollen tender abdomen.

What it is not: the queasy, full, uncomfortable feeling that is the ordinary experience of these medicines. GLP-1 nausea is unpleasant. This is pain, and it does not stop.

If you are unsure — and people are unsure, because bodies are ambiguous — that uncertainty is the reason to get seen rather than the reason to wait. Nobody in a hospital is annoyed by an abdominal pain that turns out to be severe indigestion.

What to do

Practically, in order.

  1. Go to urgent or emergency care today. Not the routine line for a call back next week. If you cannot get there yourself, ring for help.
  2. Say what you are taking, by name, in your first sentence. "I am on weekly tirzepatide" changes the differential in the clinician’s head immediately.
  3. Say how long the pain has lasted and whether you are vomiting. Those two facts drive triage.
  4. Do not eat or drink much until you have been assessed, in case they need to examine or scan you — but say so if you are already dehydrated, because that matters too.
  5. Do not take your next dose until you have been told what to do about it. This is one of the few situations where we would say wait for advice rather than keep to the schedule.
  6. Take somebody with you if you can. Pain wrecks your ability to give a history.

Assessment usually involves blood tests — amylase or lipase — and often a scan. Diagnosis is not made on symptoms alone, which is the whole reason home guesswork fails.

What the evidence actually shows

Here is where honesty is more useful than reassurance or alarm.

The large trials in this class have not demonstrated a clear excess of pancreatitis. In STEP 1 (Wilding, NEJM, 2021) cases were very few. SUSTAIN 6 (Marso, NEJM, 2016), SELECT (Lincoff, NEJM, 2023) and FLOW (Perkovic, NEJM, 2024) collectively followed large numbers of people for years without pancreatitis emerging as a headline safety signal, and the same is true across the tirzepatide programme.

At the same time, the product labels for this class carry a warning about pancreatitis, based on post-marketing reports and on the biology of a drug class acting on the pancreas. Cases have occurred in people taking these medicines. Whether at a higher rate than in a comparable population not taking them is genuinely unsettled.

Mira’s framing, which we think is the right one: this is a rare event that the trials were not sized to detect and that would be serious if it happened to you. Rare and serious is precisely the combination that justifies a low threshold for assessment and does not justify fear.

There is one clear connection worth knowing: gallstones cause pancreatitis, and gallstones are somewhat more common on these medicines and during rapid weight loss generally. The gallbladder guide covers that link.

Who should be especially careful

Things worth raising with a prescriber before starting, or at your next appointment if you have already started.

  • A previous episode of pancreatitis. This changes the conversation and, for some clinicians, the decision. Say it explicitly rather than assuming it is in the notes.
  • Known gallstones.
  • Heavy or regular alcohol use. This is a difficult thing to say to a clinician and it genuinely matters here. Our alcohol guide covers the wider picture, and there is no judgement in this community about the answer.
  • Very high triglycerides. A recognised cause of pancreatitis in its own right, and something that may be on a blood result you already have. The bloodwork guide explains where to look.
  • Certain other medicines. A number of drugs have been associated with pancreatitis. A pharmacist can review your list properly in ten minutes.
  • Family history. Worth mentioning, and worth mentioning alongside any family history of thyroid cancer, which is a separate label issue covered in the thyroid guide.

Afterwards, and the question everyone asks

Members who have been through an episode ask the same question in side-effect-support: can I go back on it.

That is entirely a clinical decision, it depends on the cause and severity, and different clinicians in different countries have come to different conclusions for different members. What we can tell you is that the conversation exists and is worth having properly rather than assuming the answer is no or assuming it is yes.

Two members have written about their episodes in the journals, and both said the same thing about the days beforehand: the pain was different from anything the medicine had done before, and they spent hours arguing with themselves about whether it was worth bothering anybody. If that is where you are as you read this, please stop arguing and go. It is what the argument is for.

And if it turns out to be nothing serious, you will have had an uncomfortable evening and a definite answer, and you will be the person in circle next month telling somebody else to go and get seen. That is how this community actually works.

Sources

  1. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002. (STEP 1 — very few pancreatitis cases; no clear excess)
  2. Marso SP, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375(19):1834–1844. (SUSTAIN 6)
  3. Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221–2232. (SELECT — multi-year follow-up in a large population)
  4. Perkovic V, et al. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med. 2024;391(2):109–121. (FLOW)
  5. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205–216. (SURMOUNT-1)

We name the trial, the journal and the year, because vague confidence is how people get hurt.

Read next

symptoms

When a symptom needs a clinician

The short list this community keeps: the symptoms that mean seek urgent care today rather than asking a forum. Written to be read once now, before anything is wrong.

9 min · reviewed by Tomás · updated 8 Jul 2026

symptoms

Gallbladder: what the data says

Gallstones turn up more often on these medicines than on placebo, and rapid weight loss causes them anyway. What the evidence supports, and the pain pattern to know.

9 min · reviewed by Sunil · updated 11 Feb 2026

symptoms

Nausea, honestly

Why nausea happens on these medicines, how common it really was in the trials, what several hundred members have found helps, and where it stops being ordinary.

9 min · reviewed by Tomás · updated 18 Apr 2026

eating

Alcohol: what changes

Many members find drinking changes on these medicines — less desire, worse effects, or both. What is actually known, and the safety points that are not negotiable.

9 min · reviewed by Benedikt · updated 30 Jun 2026

clinicalhow-to

Reading your bloodwork without panic

How to open a set of results without your stomach dropping — what a reference range actually means, which numbers move for dull reasons, and when to ring somebody today.

10 min · reviewed by Mira · updated 8 May 2026

clinicalhow-to

Talking to your GP when time is short

How to get something useful out of ten minutes — the one-page prep, the opening sentence that changes the appointment, and what to ask for in writing before you leave.

8 min · reviewed by Mira · updated 14 May 2026